Latest News
Everything thats going on at Enfold is collected here

Hey there! We are Enfold and we make really beautiful and amazing stuff.
This can be used to describe what you do, how you do it, & who you do it for.

, , , , , , , ,

CAR‐T treatment: Determining the progression‐free survival gain in patients with heavily pretreated multiple myeloma

Autori Andrea Messori Topic Analisi statistiche e metanalisi Impact factor Non ancora disponibile Abstract At the 2020 ASCO Meeting, important findings have been presented on the effectiveness of idecabtagene vicleucel (ie, CAR‐T by Bristol/Bluebird…